United Pharma IV Solutions has received three acquisition offers ranging between EGP 400 mn and 600 mn from Saudi and local investors, Al Borsa reports. According to chairman Abdallah Mahfouz, United Pharma is not looking to sell the company in its entirety, and is leaning towards expanding its shareholder base, while still maintaining the majority of shares.
More from Enterprise
Four foreign funds line up USD 256 mn for Banque du Caire
London’s Redwheel is among the backers, nearly two weeks after…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
FRA issues model short-selling contract, with launch weeks away
Contract wording is settled; the launch now waits on the…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…